Assenagon Asset Management
GHDX

Assenagon Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Assenagon Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,631
Closed -$789K – 1033
2019
Q3 		$789K Buy
+11,631
New +$799K 0.01% 604
2019
Q2 		– Sell
-267,410
Closed -$18.7M – 1249
2019
Q1 		$18.7M Buy
267,410
+194,988
+269% +$14.5M 0.18% 109
2018
Q4 		$4.67M Buy
+72,422
New +$5.08M 0.05% 250

Assenagon Asset Management's GHDX Position: Q4 2019 in Review

Assenagon Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 11,631 shares — an estimated $789K sold.

Assenagon Asset Management first reported a position in GHDX in Q4 2018 and held it in 3 quarters. The position peaked at $18.7M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Assenagon Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 11,631 Genomic Health, Inc. shares in Q4 2019, an estimated $789K.
  • Assenagon Asset Management first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 3 quarters.
  • Assenagon Asset Management's Genomic Health, Inc. position peaked at $18.7M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Assenagon Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.